Literature DB >> 3396025

In vitro activation of tumoricidal properties in mouse macrophages using the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) incorporated in liposomes.

K Morikawa1, R Nayar, I J Fidler.   

Abstract

We investigated the ability of free or liposome-incorporated synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) to generate tumoricidal properties in mouse macrophages. As FMLP contains three hydrophobic amino acid residues, it can readily be incorporated into multilamellar vesicles (MLV) consisting of phosphatidylcholine (PC) and phosphatidylserine (PS). The incorporation of FMLP into MLV with a PC:PS ratio of 7:3 mol at FMLP concentrations of up to 10(-4) M did not affect the phagocytosis of liposomes by mouse peritoneal macrophages. Studies with radioactive FMLP revealed that higher levels of FMLP can be delivered to macrophages by liposomes than in the free, nonencapsulated form. Treatment of mouse macrophages with liposome-encapsulated FMLP, but not with free FMLP, generated tumoricidal properties in the macrophages. The mechanism appears to involve an intracellular site since 100-fold concentrations of free FMLP or free N-acetyl-methionyl-leucyl-phenylalanine, the FMLP agonist, failed to competitively inhibit the macrophage's tumoricidal properties generated by liposome-encapsulated FMLP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396025     DOI: 10.1007/bf00205750

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  33 in total

Review 1.  Biochemical criteria for activated macrophages.

Authors:  M L Karnovsky; J K Lazdins
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

Review 2.  Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.

Authors:  L Chedid; C Carelli; F Audibert
Journal:  J Reticuloendothel Soc       Date:  1979-12

Review 3.  The concept of the activated macrophage.

Authors:  R J North
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

4.  The systemic activation of macrophages by liposomes containing immunomodulators.

Authors:  R Nayar; I J Fidler
Journal:  Springer Semin Immunopathol       Date:  1985

5.  Demonstration of a chemotactic factor receptor on macrophages.

Authors:  R Snyderman; E J Fudman
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

6.  The selection and characterization of an invasive variant of the B16 melanoma.

Authors:  I R Hart
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

7.  Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.

Authors:  I Saiki; I J Fidler
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

8.  Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide.

Authors:  I J Fidler; S Sone; W E Fogler; Z L Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

9.  Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C-reactive protein.

Authors:  S D Deodhar; K James; T Chiang; M Edinger; B P Barna
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

10.  The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.

Authors:  H J Showell; R J Freer; S H Zigmond; E Schiffmann; S Aswanikumar; B Corcoran; E L Becker
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.